Enveric Biosciences Inc.
11/18/2021 | Press release | Archived content
Enveric Biosciences’ CBD-Based Product Reduces Dermatitis Severity In Animal Study [Benzinga]
Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.